Ridgefield, CT, United States of America

Maria Bonatsakis Myzithras

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Bonatsakis Myzithras. Retrieved from https://idiyas.com/inventor/maria-bonatsakis-myzithras

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Bonatsakis Myzithras: Innovator in Antibody Research

Introduction

Maria Bonatsakis Myzithras is a prominent inventor based in Ridgefield, CT (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work is crucial for advancing medical research and therapeutic applications.

Latest Patents

Maria holds a patent titled "Antibodies to Connective Tissue Growth Factor (CTGF) and Uses Thereof." This patent represents her innovative approach to addressing challenges in tissue growth and repair. It highlights her expertise in antibody development and its potential applications in medicine.

Career Highlights

Maria is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role involves research and development in the field of biotechnology, where she applies her knowledge to create impactful solutions. With her dedication and expertise, she has established herself as a valuable asset in her field.

Collaborations

Maria collaborates with talented professionals such as Priyanka Gupta and Lars Dittus. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Maria Bonatsakis Myzithras is a remarkable inventor whose work in antibody research is paving the way for advancements in medical science. Her contributions are vital for the future of biotechnology and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…